This site was built with web standards. You are currently viewing the unformatted version of the website. Please update your browser in order to view the site.
Internet Explorer 5 or greater
Netscape 7
Mozilla
Opera 6 or greater
Bibliography of references used in this site and other published work relevant to this area of research:
| 1. | Boyer MJ, Tannock IF. Cellular and molecular basis of drug treatment for cancer. In: Tannock IF, Hill RP, Bristow RG, Harrington L, eds. The Basic Science of Oncology. 4th ed. New York, NY: McGraw-Hill; 2005:349–375. |
| 2. | Bristow RG, Harrington L. Genomic stability and DNA repair. In: Tannock IF, Hill RP, Bristow RG, Harrington L, eds. The Basic Science of Oncology. 4th ed. New York, NY: McGraw-Hill; 2005:77–99. |
| 3. | Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. |
| 4. | Spraycar M, ed. Stedman's Medical Dictionary. 26th ed. Baltimore, Md: Williams & Wilkins;1995:583. |
| 5. | Tannock IF, Hill RP, Bristow RG, Harrington L. Glossary. The Basic Science of Oncology. 4th ed. New York, NY: McGraw-Hill; 2005:514. |
| 6. | Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457–463. |
| 7. | Marks PA, Richon VM, Miller TA, Kelly WK. Histone deacetylase inhibitors: new targeted anticancer drugs. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005:439–445. |
| 8. | Arts J, de Schepper S, Van Emelen K. Histone deacetylase inhibitors: from chromatin remodeling to experimental cancer therapies. Curr Med Chem. 2003;10:2343–2350. |
| 9. | Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov. 2002;1:287–299. |
| 10. | de Ruijter AJM, van Gennip AH, Caron HN, Kemp S, van Kuilenburg ABP. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003;370:737–749. |
| 11. | Kelly WK, O'Connor OA, Marks PA. Histone deacetylase inhibitors: from target to trials. Expert Opin Investig Drugs. 2003;11:1695–1713. |
| 12. | Calvo KR, Petricoin EF III, Liotta LA. Genomics and proteomics. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005:51–72. |
| 13. | Di Gennaro E, Bruzzese F, Caraglia M, Abruzzese A, Budillon A. Acetylation of proteins as novel target for antitumor therapy: review article. Amino Acids. 2004;26:435–441. |
| 14. | Avers CJ. Cell control center: the nucleus. In: Basic Cell Biology. 2nd ed. Boston, Mass: Willard Grant Press; 1982:353–395. |
| 15. | Zhang Y, Reinberg D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 2001;15:2343–2360. |
| 16. | Meunier D, Seiser C. Histone deacetylase 1. In: Verdin E, ed. Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions. Totowa, NJ: Humana Press; 2006:3–22. |
